Skip to content
healthcare.dev

TOTAL PRO-JES

NDC 61657-0974, ADRENAL,BELLADONNA,CHELIDONIUM,DIOSCOREAVILLOSA,FOLLICULINUM,HYPOTHALAMUS,ARGININE,LILIumTIGRINIUM,LIVER,OOPHORINUM,PINEAL,PITUITARINUM,PLACENTANIUM,PROGESTERONE, liquid, from White Manufacturing Inc. BDA Micro-West.

Product NDC
61657-0974
Status
Listed
Labeler
White Manufacturing Inc. BDA Micro-West
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61657-0974 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PROGESTERONE6 [hp_C]/30mL
  • EPINEPHRINE6 [hp_C]/30mL
  • ATROPA BELLADONNA6 [hp_C]/30mL
  • CHELIDONIUM MAJUS6 [hp_C]/30mL
  • DIOSCOREA VILLOSA ROOT6 [hp_C]/30mL
  • ESTRONE6 [hp_C]/30mL
  • BOS TAURUS HYPOTHALAMUS6 [hp_C]/30mL
  • ARGININE6 [hp_X]/30mL
  • LILIUM LANCIFOLIUM FLOWERING TOP12 [hp_C]/30mL
  • MAMMAL LIVER6 [hp_C]/30mL
  • SUS SCROFA OVARY6 [hp_C]/30mL
  • BOS TAURUS PINEAL GLAND6 [hp_X]/30mL
  • BOS TAURUS PITUITARY GLAND6 [hp_X]/30mL
  • SUS SCROFA PLACENTA6 [hp_X]/30mL
  • PULSATILLA VULGARIS12 [hp_C]/30mL
  • SEPIA OFFICINALIS JUICE12 [hp_C]/30mL
  • SULFUR12 [hp_C]/30mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]; Progesterone [CS]; Progesterone [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
61657-0974-16165709740130 mL in 1 BOTTLE, DROPPER (61657-0974-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 61657-0974 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61657-0974 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61657-0974. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.